Published in J Clin Invest on June 01, 1970
Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol (1984) 1.82
Glomerular complement components in human glomerulonephritis. J Clin Invest (1974) 1.43
Synthesis of basement membrane collagen by cultured human endothelial cells. J Exp Med (1976) 1.27
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane. Clin Exp Immunol (1987) 1.01
The production of precipitating antiglobulin reagents specific for the subclasses of human IgG. Immunology (1974) 0.95
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal? J Clin Pathol (1989) 0.95
Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis. Clin Exp Immunol (1978) 0.93
Autoimmune glomerulotubular nephropathy in mice. Clin Exp Immunol (1978) 0.92
IgG3 levels in patients with chronic membranoproliferative glomerulonephritis. Br Med J (1972) 0.92
Antigammaglobulin (rheumatoid factor) activity of human IgG subclasses. Ann Rheum Dis (1978) 0.86
The influence of genotype on the development of glomerular lesions in mink with Aleutian disease virus. Am J Pathol (1975) 0.83
Autoantibodies against C1q as a Diagnostic Measure of Lupus Nephritis: Systematic Review and Meta-analysis. J Clin Cell Immunol (2014) 0.80
Contributions of renal biopsy studies to the understanding of disease. Am J Pathol (1971) 0.78
C4 in glomerular lesions of NZB/NZW mice. Clin Exp Immunol (1977) 0.76
QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol (1965) 16.97
Zone electrophoresis in a starch supporting medium. Proc Soc Exp Biol Med (1952) 13.49
Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med (1961) 10.94
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med (1965) 7.16
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med (1965) 5.86
Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med (1968) 5.72
H CHAIN SUBGROUPS OF MYELOMA PROTEINS AND NORMAL 7S GAMMA-GLOBULIN. J Exp Med (1964) 5.64
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Differences in anti-protein A activity among IgG subgroups. J Immunol (1969) 4.56
IgA glomerular deposits in renal disease. Transplant Proc (1969) 4.19
Experimental glomerulonephritis. II. Immunologic events in the pathogenesis of nephrotoxic serum nephritis in the rat. J Exp Med (1963) 4.17
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37
IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM. J Exp Med (1964) 1.99
Immune complex disease. I. Experimental acute and chronic glomerulonephritis. Johns Hopkins Med J (1967) 1.41
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95
On standard definitions: 33 years hence. Arch Dermatol (1997) 4.32
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med (1982) 3.40
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31
The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Dermatol Online J (1997) 2.68
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
A computer based intervention to reduce unnecessary serologic testing. J Rheumatol (1999) 2.37
Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis (2003) 2.33
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum (1994) 1.97
Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) (1981) 1.83
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci U S A (1987) 1.81
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1969) 1.79
Complement in human disease. Annu Rev Med (1968) 1.79
Immunohistochemistry of glomerulonephritis using horseradish peroxidase and fluorescein-labeled antibody: a comparison of two technics. Am J Clin Pathol (1970) 1.79
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum (1968) 1.72
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet (1970) 1.70
Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med (1973) 1.69
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med (1997) 1.66
Immunologic studies of juvenile rheumatoid arthritis. Arthritis Rheum (1972) 1.65
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Survival data for patients undergoing chronic intermittent hemodialysis. Ann Intern Med (1969) 1.58
Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum (1983) 1.56
Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis (1989) 1.55
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum (1972) 1.51
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50
Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med (1995) 1.50
Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis (1990) 1.49
Human renal allografts. The role of vascular injury in early graft failure. Medicine (Baltimore) (1971) 1.49
Hypocomplementemia in rheumatoid arthritis. Arthritis Rheum (1971) 1.48
Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med (1980) 1.47
Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann N Y Acad Sci (1969) 1.46
IgG subclasses--a review. Ann Allergy (1987) 1.45
Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol (1987) 1.44
Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis). Appl Environ Microbiol (1998) 1.43
Immunoglobulin subclasses in normal children. Pediatr Res (1979) 1.42
Fish-oil-containing diet and platelet aggregation. Nutrition (1993) 1.42
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.41
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. Clin Exp Immunol (1974) 1.39
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. J Clin Invest (1976) 1.38
Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J Biol Chem (1983) 1.37
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis (1999) 1.37
Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum (1979) 1.36
Human gamma-g subclasses. Prog Clin Immunol (1972) 1.35
A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest (1990) 1.35
Prevalence of Cryptosporidium, Giardia and Eimeria infections in post-weaned and adult cattle on three Maryland farms. Vet Parasitol (2000) 1.34
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant (1998) 1.34
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest (1985) 1.32
Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med (1973) 1.31
pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. J Immunol Methods (1979) 1.31
Rheumatoid arthritis associated with eosinophilia. Ann Intern Med (1971) 1.29
The gammaG subclass of antinuclear and antinucleic acid antibodies. Arthritis Rheum (1972) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology (2001) 1.27
The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol (1988) 1.27
Inherited deficiency of the sixth component of complement: a silent or null gene. J Immunol (1978) 1.27
Survival of infectious Cryptosporidium parvum oocysts in seawater and eastern oysters (Crassostrea virginica) in the Chesapeake Bay. Appl Environ Microbiol (1998) 1.27
An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol (1971) 1.27
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol (1974) 1.26
Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis Rheum (1976) 1.26
Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) (1978) 1.25
Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med (1974) 1.24
Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. J Lab Clin Med (1974) 1.24
Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation (1970) 1.23
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. Arthritis Rheum (1975) 1.21
Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum (1983) 1.21
Potential Role of the Eastern Oyster, Crassostrea virginica, in the Epidemiology of Cryptosporidium parvum. Appl Environ Microbiol (1997) 1.21
Development of reticulum cell sarcoma during cyclophosphamide therapy. Arthritis Rheum (1974) 1.21
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases. J Exp Med (1971) 1.20
Re-examination of histocompatibility antigens found in patients with juvenile rheumatoid arthritis. N Engl J Med (1975) 1.20
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum (1992) 1.19
Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med (1975) 1.17